Quarterly report pursuant to Section 13 or 15(d)

Equity-Based Compensation

v3.21.2
Equity-Based Compensation
9 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Equity-Based Compensation Equity-Based CompensationDuring the fiscal year ended September 30, 2019, the Company awarded a total of 292,534 restricted shares of Class A common stock to its non-employee directors under the Equity Incentive Plan in lieu of any cash compensation. The grants are classified as equity awards. The aggregate grant date fair value of these restricted awards was $3.8 million. During the three and nine months ended June 30, 2021, the Company recorded compensation expense in connection with these grants in the amount of $0.3 million and $1.0 million, respectively, which is reflected as general and administrative expenses in the Company’s Consolidated Statements of Income. At June 30, 2021, there was approximately $0.7 million of unrecognized compensation expense related to these awards.
During the quarter ended March 31, 2021, the Company awarded a total of 510,733 restricted shares of Class A common stock to Company management under the Equity Incentive Plan. The grants are classified as equity awards. The aggregate grant date fair value of these restricted awards was $13.6 million. During the three and nine months ended June 30, 2021, the Company recorded compensation expense in connection with these grants in the amount of $1.0 million and $1.2 million, respectively, which is reflected as general and administrative expenses in the Company’s Consolidated Statements of Income. At June 30, 2021, there was approximately $12.4 million of unrecognized compensation expense related to these awards.
The underlying shares subject to awards granted under the Equity Incentive Plan vested or will vest, as applicable, as follows:
Fiscal Year Number of Shares
2021 207,706 
2022 110,194 
2023 12,683 
2024 242,684 
2025 230,000 
Total 803,267